|
1
|
Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial.
|
Ann Surg
|
2009
|
2.19
|
|
2
|
Different cava reconstruction techniques in liver transplantation: piggyback versus cava resection.
|
Hepatobiliary Pancreat Dis Int
|
2014
|
2.08
|
|
3
|
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
|
Ann Surg
|
2013
|
1.98
|
|
4
|
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.
|
Transpl Int
|
2009
|
1.77
|
|
5
|
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial.
|
Ann Surg
|
2008
|
1.74
|
|
6
|
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.
|
Liver Int
|
2011
|
1.57
|
|
7
|
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
|
Liver Transpl
|
2008
|
1.47
|
|
8
|
Single shot of alemtuzumab as induction therapy after kidney transplantation is sufficient.
|
Transpl Int
|
2011
|
1.39
|
|
9
|
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.
|
Neuroendocrinology
|
2012
|
1.38
|
|
10
|
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.
|
J Immunol
|
2011
|
1.25
|
|
11
|
Age and immune response in organ transplantation.
|
Transplantation
|
2005
|
1.23
|
|
12
|
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration.
|
Clin Transplant
|
2009
|
1.06
|
|
13
|
Extended surgical resection for xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma: A case report and review of literature.
|
World J Gastroenterol
|
2006
|
1.05
|
|
14
|
In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).
|
Hepatology
|
2004
|
1.03
|
|
15
|
Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.
|
Neuroendocrinology
|
2009
|
1.02
|
|
16
|
Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases.
|
Haematologica
|
2011
|
0.98
|
|
17
|
Psychosocial outcome of living donors after living donor liver transplantation: a pilot study.
|
Clin Transplant
|
2002
|
0.97
|
|
18
|
Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation.
|
Transpl Int
|
2008
|
0.97
|
|
19
|
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.
|
Transplantation
|
2010
|
0.96
|
|
20
|
Graft versus host disease after liver transplantation - a single center experience and review of literature.
|
Transpl Int
|
2008
|
0.96
|
|
21
|
A comparison of three scores to screen for delirium on the surgical ward.
|
World J Surg
|
2010
|
0.91
|
|
22
|
Long-term outcome of liver resection and transplantation for Caroli disease and syndrome.
|
Ann Surg
|
2008
|
0.91
|
|
23
|
Potent early immune response after kidney transplantation in patients of the European senior transplant program.
|
Transplantation
|
2009
|
0.89
|
|
24
|
68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.
|
J Nucl Med
|
2011
|
0.89
|
|
25
|
Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra) in liver transplantation: an open, prospective, single-arm phase III study.
|
Transpl Int
|
2011
|
0.88
|
|
26
|
Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function.
|
J Hepatol
|
2003
|
0.88
|
|
27
|
Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
|
J Gastroenterol Hepatol
|
2007
|
0.86
|
|
28
|
Well-differentiated neuroendocrine carcinoma mimicking an echinococcus cyst of the liver in CT-MRI findings with hepatocyte specific contrast material.
|
J Gastrointestin Liver Dis
|
2011
|
0.86
|
|
29
|
Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction.
|
Transplantation
|
2006
|
0.85
|
|
30
|
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.
|
Transpl Int
|
2012
|
0.85
|
|
31
|
US-based Real-time Elastography for the Detection of Fibrotic Gut Tissue in Patients with Stricturing Crohn Disease.
|
Radiology
|
2015
|
0.85
|
|
32
|
Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation.
|
Transplantation
|
2013
|
0.85
|
|
33
|
Can we use biomarkers and functional assays to implement personalized therapies in transplantation?
|
Transplantation
|
2009
|
0.85
|
|
34
|
Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome.
|
Transplantation
|
2010
|
0.84
|
|
35
|
Management of biliary complications following living donor liver transplantation--a single center experience.
|
Langenbecks Arch Surg
|
2009
|
0.84
|
|
36
|
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
|
Transpl Int
|
2009
|
0.84
|
|
37
|
Aspergillus spondylodiscitis after multivisceral transplantation.
|
Ann Transplant
|
2009
|
0.84
|
|
38
|
Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
|
Eur J Radiol
|
2013
|
0.82
|
|
39
|
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
|
Liver Transpl
|
2007
|
0.82
|
|
40
|
Technical advances for abdominal wall closure after intestinal and multivisceral transplantation.
|
Curr Opin Organ Transplant
|
2012
|
0.82
|
|
41
|
DTG procurement guidelines in heart beating donors.
|
Transpl Int
|
2011
|
0.82
|
|
42
|
The utility of extended criteria donor organs in severely ill liver transplant recipients.
|
Transplantation
|
2008
|
0.82
|
|
43
|
Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation.
|
Transpl Int
|
2014
|
0.81
|
|
44
|
Long-term outcome of ATG vs. Basiliximab induction.
|
Eur J Clin Invest
|
2011
|
0.81
|
|
45
|
Donor brain death significantly interferes with tolerance induction protocols.
|
Transpl Int
|
2008
|
0.81
|
|
46
|
Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia.
|
Neuroendocrinology
|
2015
|
0.80
|
|
47
|
Impaired psychosocial outcome of donors after living donor liver transplantation: a qualitative case study.
|
Clin Transplant
|
2006
|
0.80
|
|
48
|
Short-term anti-CD4 plus anti-TNF-alpha receptor treatment in allogeneic small bowel transplantation results in long-term survival.
|
Transplantation
|
2007
|
0.80
|
|
49
|
Continuously microscopically observed and process-controlled cell culture within the SlideReactor: proof of a new concept for cell characterization.
|
Tissue Eng
|
2007
|
0.80
|
|
50
|
Living-donor liver transplantation--European experiences.
|
Nephrol Dial Transplant
|
2004
|
0.80
|
|
51
|
[Living donor liver transplantation from the perspective of the donor: results of a psychosomatic investigation].
|
Z Psychosom Med Psychother
|
2005
|
0.79
|
|
52
|
Ischemic preconditioning produces systemic protective and adoptively transferable effects.
|
Kidney Int
|
2008
|
0.79
|
|
53
|
Influence of donor- and recipient-specific factors on the postoperative course after combined pancreas-kidney transplantation.
|
Langenbecks Arch Surg
|
2010
|
0.78
|
|
54
|
Gender Matches in Liver Transplant Allocation: Matched and Mismatched Male-Female Donor-Recipient Combinations; Long-term Follow-up of More Than 2000 Patients at a Single Center.
|
Exp Clin Transplant
|
2016
|
0.78
|
|
55
|
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
|
HPB (Oxford)
|
2014
|
0.78
|
|
56
|
Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantation.
|
Transplantation
|
2014
|
0.78
|
|
57
|
Extended indications in living-donor liver transplantation: bile duct cancer.
|
Transplantation
|
2005
|
0.78
|
|
58
|
Evaluation of domino liver transplantations in Germany.
|
Transpl Int
|
2013
|
0.78
|
|
59
|
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion.
|
Transplant Res
|
2013
|
0.78
|
|
60
|
The APACHE III score as preoperative indicator of patient outcome in liver transplantation after fulminant hepatic failure.
|
Ann Transplant
|
2011
|
0.77
|
|
61
|
Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib.
|
Transpl Int
|
2010
|
0.77
|
|
62
|
An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
|
World J Gastroenterol
|
2007
|
0.76
|
|
63
|
Treatment of postoperative ileus with choline citrate--results of a prospective, randomised, placebo-controlled, double-blind multicentre trial.
|
Int J Colorectal Dis
|
2011
|
0.76
|
|
64
|
Quantification in Ga-DOTA(0)-Phe(1)-Tyr(3)-octreotide positron emission tomography/computed tomography: can we be impartial about partial volume effects?
|
Neuroendocrinology
|
2013
|
0.76
|
|
65
|
The impact of immune-activating processes following transplantation on chronic allograft nephropathy.
|
Kidney Int
|
2003
|
0.76
|
|
66
|
State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression.
|
Curr Opin Organ Transplant
|
2010
|
0.76
|
|
67
|
Immune reactivity is more suppressed in patients with alcoholic liver disease than in patients with virus-induced cirrhosis after CRH stimulation.
|
Alcohol Clin Exp Res
|
2006
|
0.76
|
|
68
|
Tumor DNA Index and α-Fetoprotein Level Define Outcome following Liver Transplantation for Advanced Hepatocellular Carcinoma.
|
Eur Surg Res
|
2015
|
0.76
|
|
69
|
Extended pancreas donor program - the EXPAND study rationale and study protocol.
|
Transplant Res
|
2013
|
0.75
|
|
70
|
How successful is intestinal transplantation and what improves graft survival?
|
Nat Clin Pract Gastroenterol Hepatol
|
2005
|
0.75
|
|
71
|
Waitlist characteristics of patients at a single-center intestinal and multivisceral transplant program.
|
Transpl Int
|
2013
|
0.75
|
|
72
|
HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
|
Transplantation
|
2016
|
0.75
|
|
73
|
Organ donation: when should we consider intestinal donation.
|
Transpl Int
|
2012
|
0.75
|
|
74
|
Cardiovascular risk and events after liver transplantation. Experiences from 313 consecutive transplants with a follow-up of 20 years.
|
Clin Transplant
|
2015
|
0.75
|
|
75
|
Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
|
Transplantation
|
2017
|
0.75
|
|
76
|
Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
|
Transplantation
|
2017
|
0.75
|
|
77
|
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation.
|
Transplantation
|
2017
|
0.75
|
|
78
|
Survival without biliary complications after liver transplant for primary sclerosing cholangitis.
|
Exp Clin Transplant
|
2013
|
0.75
|
|
79
|
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.
|
Neuroendocrinology
|
2017
|
0.75
|
|
80
|
Cold ischemia does not interfere with tolerance induction.
|
Transplantation
|
2009
|
0.75
|
|
81
|
Pharmacological strategies to enhance adaptation in intestinal failure.
|
Curr Opin Organ Transplant
|
2016
|
0.75
|
|
82
|
Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.
|
J Gastrointest Surg
|
2014
|
0.75
|
|
83
|
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
|
Neuroendocrinology
|
2017
|
0.75
|